Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The accuracy and cost-effectiveness of hepatitis C core antigen assay in the monitoring of anti-viral therapy in patients with chronic hepatitis C genotype 4.

Alimentary pharmacology & therapeutics - 1 Aug 2015

Kamal S M, Kassim S, El Gohary E, Fouad A, Nabegh L, Hafez T, Bahnasy K, Hassan H, Ghoraba D

Abstract excerpt

BACKGROUND: Quantitative hepatitis C (HCV) polymerase chain reaction (qtHCV-PCR), the gold standard for monitoring HCV therapy, is an expensive, time-consuming procedure that requires equipped laboratories and trained personnel. AIMS: To assess the accuracy and cost-effectiveness of the automated Abbott ARCHITECT HCV Ag assay (Wiesbaden, Germany) in monitoring response to pagylated interferon (PEG-IFN) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Hepatitis C Antigens

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Longitudinal Studies

Share to Ribavirin

Source

Identifiers

PMID: 26018116
DOI: 10.1111/apt.13261

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The accuracy and cost-effectiveness of hepatitis C core antigen assay in the monitoring of anti-viral therapy in patients with chronic hepatitis C genotype 4.PMID 26018116Read ↗

Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis.Semantic proximity Read ↗

Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay.Semantic proximity Read ↗

Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assaySemantic proximity Read ↗

Real-world utility of HCV core antigen as an alternative to HCV RNA testing: Implications for viral load and genotype.Semantic proximity Read ↗

Fast, reliable and low cost user-developed protocol for detection, quantification and genotyping of hepatitis C virus.Semantic proximity Read ↗

The Cobas AmpliPrep/Cobas TaqMan HCV test, version 2.0, real-time PCR assay accurately quantifies hepatitis C virus genotype 4 RNA.Semantic proximity Read ↗

Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection.Semantic proximity Read ↗

Diagnostic Reliability of Architect Anti-HCV Tests and Diagnostic Cost of False Positivity; A Single Center Study in Turkey.Semantic proximity Read ↗

Performance of the COBAS® AmpliPrep/COBAS TaqMan® automated system for hepatitis C virus (HCV) quantification in a multi-center comparison.Semantic proximity Read ↗

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.Semantic proximity Read ↗

HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patients.Semantic proximity Read ↗

Evaluation of the new cobas® HCV genotyping test based on real-time PCRs of three different HCV genome regions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.